Evidence map›Paper›PMID 37554732›Full record

ArticleFrontiers in public health2023

The HEARTS partner forum-supporting implementation of HEARTS to treat and control hypertension.

Taskeen Khan, Andrew E Moran, Pablo Perel, Paul K Whelton, Michael Brainin, Valery Feigin, Deliana Kostova, Patricia Richter, Pedro Ordunez, Anselm Hennis and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. CARDIO4Cities: A roadmap for improving urban cardiovascular health.American journal of preventive cardiology · 2026
    Article
  6. Review
  7. Evolution in the targets for blood pressure treatment.Current opinion in nephrology and hypertension · 2026
    Review
  8. Article
  9. Article
  10. Healthcare providers' perceptions of the HEARTS Clinical Pathway in Belize: barriers and facilitators.Revista panamericana de salud publica = Pan American journal of public health · 2026
    Article
  11. Article
  12. Review
  13. Population-based approaches to increase hypertension control: an urgent need.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 8 countries.

Taskeen KhanDepartment of Non-communicable Diseases, World Health Organization, Geneva, Switzerland.
Andrew E MoranResolve to Save Lives, New York, NY, United States.
Pablo PerelCentre for Global Chronic Conditions, Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Paul K WheltonDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, United States.
Michael BraininDepartment of Clinical Neurology, Danube University, Krems, Austria.
Valery FeiginWorld Stroke Organization, Geneva, Switzerland.
Deliana KostovaDivision of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Non-communicable Diseases and Mental Health, Atlanta, GA, United States.
Patricia RichterDivision of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Non-communicable Diseases and Mental Health, Atlanta, GA, United States.
Pedro OrdunezPan American Health Organization/World Health Organization, Washington, DC, United States.
Anselm HennisPan American Health Organization/World Health Organization, Washington, DC, United States.
Daniel T LacklandWorld Hypertension League, New Orleans, LA, United States.
Slim SlamaDepartment of Non-communicable Diseases, World Health Organization, Geneva, Switzerland.
Daniel PineiroWorld Heart Federation, Geneva, Switzerland.
Sheila MartinsWorld Stroke Organization, Geneva, Switzerland.
Bryan WilliamsInternational Society of Hypertension, Essex, United Kingdom.
Leonard HofstraAmsterdam UMC-Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Renu GargResolve to Save Lives, New York, NY, United States.
Bente MikkelsenDepartment of Non-communicable Diseases, World Health Organization, Geneva, Switzerland.
European Stroke Organisation · CHWorld Health Organization · CHWorld Health Organization Regional Office for the Americas · USCenter for Global Health · USCenters for Disease Control and Prevention · USColumbia University · USInternational Society of HypertensionLondon School of Hygiene & Tropical Medicine · GBMedical University of South Carolina · USTulane University · USVrije Universiteit Amsterdam · NLWorld Heart Federation · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

Cardiovascular diseases (CVD), principally ischemic heart disease (IHD) and stroke, are the leading causes of death (18. 6 million deaths annually) and disability (393 million disability-adjusted life-years lost annually), worldwide. High blood pressure is the most important preventable risk factor for CVD and deaths, worldwide (10.8 million deaths annually). In 2016, the World Health Organization (WHO) and the United States Centers for Disease Control (CDC) launched the Global Hearts initiative to support governments in their quest to prevent and control CVD. HEARTS is the core technical package of the initiative and takes a public health approach to treating hypertension and other CVD risk factors at the primary health care level. The HEARTS Partner Forum, led by WHO, brings together the following 11 partner organizations: American Heart Association (AHA), Center for Chronic Disease Control (CCDC), International Society of Hypertension (ISH), International Society of Nephrology (ISN), Pan American Health Organization (PAHO), Resolve to Save Lives (RTSL), US CDC, World Hypertension League (WHL), World Heart Federation (WHF) and World Stroke Organization (WSO). The partners support countries in their implementation of the HEARTS technical package in various ways, including providing technical expertise, catalytic funding, capacity building and evidence generation and dissemination. HEARTS has demonstrated the feasibility and acceptability of a public health approach, with more than seven million people already on treatment for hypertension using a simple, algorithmic HEARTS approach. Additionally, HEARTS has demonstrated the feasibility of using hypertension as a pathfinder to universal health coverage and should be a key intervention of all basic benefit packages. The partner forum continues to find ways to expand support and reinvigorate enthusiasm and attention on preventing CVD. Proposed future HEARTS Partner Forum activities are related to more concrete information sharing between partners and among countries, expanded areas of partner synergy, support for implementation, capacity building, and advocacy with country ministries of health, professional societies, academy and civil societies organizations. Advancing toward the shared goals of the HEARTS partners will require a more formal, structured approach to the forum and include goals, targets and published reports. In this way, the HEARTS Partner Forum will mirror successful global partnerships on communicable diseases and assist countries in reducing CVD mortality and achieving global sustainable development goals (SDGs).

Indexed as

Cardiovascular DiseasesHypertensionStrokeHumansRisk FactorsUnited Statescardiovascular diseasesglobal healthhealth systemshypertensionimplementationpartnershipsprimary healthcareuniversal health coverage

Identifiers

PMID37554732
PMCPMC10405076
OpenAlexW4385223596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.